BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8945580)

  • 1. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells.
    Mahon BP; Ryan MS; Griffin F; Mills KH
    Infect Immun; 1996 Dec; 64(12):5295-301. PubMed ID: 8945580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
    Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
    Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice.
    Ryan M; Gothefors L; Storsaeter J; Mills KH
    Dev Biol Stand; 1997; 89():297-305. PubMed ID: 9272363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
    Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
    PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model.
    Kang KR; Huh DH; Kim JA; Kang JH
    BMC Immunol; 2021 Oct; 22(1):68. PubMed ID: 34641798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
    Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
    BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
    Redhead K; Watkins J; Barnard A; Mills KH
    Infect Immun; 1993 Aug; 61(8):3190-8. PubMed ID: 8335349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations].
    Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
    Med Dosw Mikrobiol; 2007; 59(2):137-47. PubMed ID: 17929411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
    Lavigne MV; Castro M; Andino J; Manghi M
    Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen.
    Lavigne MV; Castro M; Mateo N; Deluchi S; Atzori C; Piudo L; Calcagno M; Brero ML; Manghi M
    Microbes Infect; 2002 Jul; 4(8):815-20. PubMed ID: 12270728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
    Mills KH; Ryan M; Ryan E; Mahon BP
    Infect Immun; 1998 Feb; 66(2):594-602. PubMed ID: 9453614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity.
    Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH
    J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
    Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
    Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
    Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
    Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
    Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA
    Front Immunol; 2019; 10():1520. PubMed ID: 31333656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
    Dunne A; Mielke LA; Allen AC; Sutton CE; Higgs R; Cunningham CC; Higgins SC; Mills KH
    Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines.
    Canthaboo C; Williams L; Xing DK; Corbel MJ
    Vaccine; 2000 Nov; 19(6):637-43. PubMed ID: 11090715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response.
    Rieber N; Graf A; Hartl D; Urschel S; Belohradsky BH; Liese J
    PLoS One; 2011 Mar; 6(3):e17271. PubMed ID: 21408149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
    van den Berg BM; David S; Beekhuizen H; Mooi FR; van Furth R
    Vaccine; 2000 Dec; 19(9-10):1118-28. PubMed ID: 11137247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.